Ignelzi Troy A. bought RAPP

October 21, 2026 · Form 4 insider transaction

Ignelzi Troy A. bought 5,500 shares of Rapport Therapeutics, Inc. at $26.10 per share, a transaction worth $143.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.